標(biāo)題: Titlebook: Methods and Biostatistics in Oncology; Understanding Clinic Raphael. L.C Araújo,Rachel P. Riechelmann Book 2018 Springer International Publ [打印本頁(yè)] 作者: 搭話 時(shí)間: 2025-3-21 18:55
書目名稱Methods and Biostatistics in Oncology影響因子(影響力)
書目名稱Methods and Biostatistics in Oncology影響因子(影響力)學(xué)科排名
書目名稱Methods and Biostatistics in Oncology網(wǎng)絡(luò)公開度
書目名稱Methods and Biostatistics in Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Methods and Biostatistics in Oncology被引頻次
書目名稱Methods and Biostatistics in Oncology被引頻次學(xué)科排名
書目名稱Methods and Biostatistics in Oncology年度引用
書目名稱Methods and Biostatistics in Oncology年度引用學(xué)科排名
書目名稱Methods and Biostatistics in Oncology讀者反饋
書目名稱Methods and Biostatistics in Oncology讀者反饋學(xué)科排名
作者: 說(shuō)明 時(shí)間: 2025-3-21 23:04
The Many Different Designs of Phase II Trials in Oncology,continuation trials, and crossover studies. The aim of this chapter is to provide an overview of the different designs of phase II cancer trials and to discuss the advantages and disadvantages of each design.作者: mosque 時(shí)間: 2025-3-22 02:27
Cost-Effectiveness Studies in Oncology,question. In addition, cost-effectiveness studies must be transparent and reproducible. Physicians need to be able to understand and critically assess the quality of a pharmacoeconomic study. In this review, we will discuss how the cost of cancer care can be studied and how the data can be applied in oncology to guide health policy decisions.作者: 滲入 時(shí)間: 2025-3-22 05:41 作者: Autobiography 時(shí)間: 2025-3-22 11:27 作者: 影響 時(shí)間: 2025-3-22 16:58
Design of Retrospective and Case-Control Studies in Oncology,y; types of biases; sampling and matching techniques, including propensity score matching; missing data; and special considerations for common study designs. Examples from the surgical oncology literature are provided.作者: Cacophonous 時(shí)間: 2025-3-22 20:17 作者: BRUNT 時(shí)間: 2025-3-23 00:39 作者: 場(chǎng)所 時(shí)間: 2025-3-23 03:08 作者: 胎兒 時(shí)間: 2025-3-23 06:45 作者: altruism 時(shí)間: 2025-3-23 13:06
Testing Measures of Associations,etermining whether a parametric test or a nonparametric test would be more appropriate. In this chapter we will discuss the characteristics of the tests of measures of association commonly performed in clinical cancer research, when to use the tests, and how to interpret the accuracy of their results.作者: Preamble 時(shí)間: 2025-3-23 15:45
Interpretation of Results from Tables, Graphs, and Regressions in Cancer Research,mes in clinical research are univariate regression and multivariate regression; here we describe the use of these methods. However, despite being widely used in cancer research, these tools are not easily interpreted, are sometimes overused, and may be associated with hidden biases.作者: 玩忽職守 時(shí)間: 2025-3-23 18:05 作者: CRUE 時(shí)間: 2025-3-24 01:04
Identifying Bias in Clinical Cancer Research,ty to avoid the introduction of bias in cancer research. In this chapter we discuss the most frequent types of bias encountered in clinical oncology research, as well as potential solutions to minimize them.作者: minimal 時(shí)間: 2025-3-24 05:01 作者: BANAL 時(shí)間: 2025-3-24 09:11
https://doi.org/10.1007/978-3-319-71324-3Oncology; Clinical research; Outcomes; Biostatistics; Research; Methods; Methodology作者: 礦石 時(shí)間: 2025-3-24 14:43 作者: 滋養(yǎng) 時(shí)間: 2025-3-24 18:38
How to Design Phase I Trials in Oncology, in combination, in human trial participants. To achieve these objectives, preclinical data, trial design methodology and dose selection should be carefully considered and assimilated. In the following chapter the fundamental principles of phase 1 trial design will be outlined.作者: 過(guò)時(shí) 時(shí)間: 2025-3-24 19:49
Raphael. L.C Araújo,Rachel P. RiechelmannA tailor-made book on clinical research and biostatistics in oncology.Focuses on practical and applicable knowledge and usefulness in daily practice, allowing readers to properly appraise literature.A作者: 干涉 時(shí)間: 2025-3-25 02:05 作者: 豐滿有漂亮 時(shí)間: 2025-3-25 07:20 作者: 不能強(qiáng)迫我 時(shí)間: 2025-3-25 09:38 作者: Inferior 時(shí)間: 2025-3-25 14:05 作者: 包裹 時(shí)間: 2025-3-25 18:46
Superiority and Non-inferiority Phase III Oncology Trials,the control arm; dropout, or the expected rate of loss to follow-up or loss of data; experimental, or the desired result in the experimental arm, using the same parameter type as for C) is offered to facilitate interaction between clinical trialists and statisticians. Blocked randomization, stratifi作者: Myosin 時(shí)間: 2025-3-25 20:57
Meta-Research in Oncology,ortunity for clinical scientists residing in low-income countries. In this chapter, we present the principles of designing and conducing meta-research and use our experience to suggest instructions on how to perform this type of study.作者: 北極人 時(shí)間: 2025-3-26 03:10 作者: 把手 時(shí)間: 2025-3-26 07:54
Louise Carter M.A., M.B.B.S., Ph.D., M.R.C.P.,Ciara O’Brien B.Sc., M.B.B.S., Ph.D.,Emma Dean B.MedScms using combinatorial techniques, it has also been the source of many new combinatorial problems. One example is - dio channel assignment. In this problem we h978-1-4684-9268-2978-0-387-22444-2Series ISSN 1613-5237 Series E-ISSN 2197-4152 作者: colloquial 時(shí)間: 2025-3-26 08:41 作者: 整理 時(shí)間: 2025-3-26 16:02
g of the issues is estimated. As our agent adopts a fixed time-based concession strategy and takes the estimated issue importance ranks into account, it determines to what extent the issues are to be modified. The evaluation results of the ANAC 2020 show that our agent beats the other participating 作者: CURT 時(shí)間: 2025-3-26 17:47
Vinicius de Lima Vazquez M.D., Ph.D.,Raphael L. C. Araújo M.D., Ph.D.d of the negotiation. In addition, our agent can adjust the speed of compromise by judging the opponent’s Thomas-Kilmann Conflict (TKI) Mode and search for the pareto frontier using past negotiation sessions. In the experiments, we demonstrate that our agent won the ANAC-2013 qualifying round regard作者: upstart 時(shí)間: 2025-3-26 21:22
Beatriz Teixeira Costa,Isadora Santos Ferreira,Felipe Fregni M.D., Ph.D., M.P.H.tiating agents on a traffic simulation, as well as its parameter tuning process on GPU-based programming for simulation developers to utilize GPGPU-based many parallel cores in their simulation programs efficiently. We show how our implemented prototype framework helps simulation developers optimize作者: amorphous 時(shí)間: 2025-3-27 04:21 作者: Foregery 時(shí)間: 2025-3-27 07:09 作者: flamboyant 時(shí)間: 2025-3-27 12:07
Rachel P. Riechelmann M.D., Ph.D.,Raphael L. C. Araújo M.D., Ph.D.,Benjamin Haaland Ph.D.rning methods. Since different agents use different machine learning methods, the recommendations they make may be conflicting. Negotiation is used to come to an agreement on a recommendation. Negotiation is conducted using a . protocol. The performance of MARS is evaluated in terms of recommendatio作者: Desert 時(shí)間: 2025-3-27 17:10 作者: 蜈蚣 時(shí)間: 2025-3-27 18:00 作者: amputation 時(shí)間: 2025-3-27 23:31 作者: MIR 時(shí)間: 2025-3-28 04:08
Katherine S. Panageas Dr.P.H.,Debra A. Goldman M.S.,T. Peter Kingham M.D.nd box products, which allows us to compute the Newton step efficiently. Whereas the direct computation requires . storage and . operations, the indirect representation of the Hessian allows the storage to be reduced to ., where . is the number of times the variable . occurs in the expression for th作者: FLOAT 時(shí)間: 2025-3-28 09:07
Rachel P. Riechelmann M.D., Ph.D.,Raphael L. C. Araújo M.D., Ph.D.,Axel Hinke Ph.D.ic microbial corrosion is inherently a complex process; experimental analyses have largely been carried out with pure cultures of sulphate-reducing bacteria..The sulphate-reducing bacteria are found in nature as components of mixed microbial communities, or consortia which often exist as biofilms co作者: 詢問(wèn) 時(shí)間: 2025-3-28 11:27 作者: 不遵守 時(shí)間: 2025-3-28 16:35
Deise Uema M.D.,Cheng Tzu Yen M.D.,Axel Hinke Ph.D.,Gilberto de Castro Jr. M.D., Ph.D.iologically active therein. Alternatively some antibiotics at low concentrations (especially concentrations below the MIC’s) have been shown to modify the introduction of various bacteria with PMNL. Again clindamycin has been shown to repress polysaccharide capsule biosynthesis in ., and by so doing作者: 沒收 時(shí)間: 2025-3-28 21:22 作者: epinephrine 時(shí)間: 2025-3-28 23:08
Rodrigo Santa C. Guindalini M.D., Ph.D.,Rachel P. Riechelmann M.D., Ph.D.,Roberto Jun Arai M.Sc., Phiologically active therein. Alternatively some antibiotics at low concentrations (especially concentrations below the MIC’s) have been shown to modify the introduction of various bacteria with PMNL. Again clindamycin has been shown to repress polysaccharide capsule biosynthesis in ., and by so doing作者: Flat-Feet 時(shí)間: 2025-3-29 05:15
Pedro Aguiar Jr. M.D.,Carmelia Maria Noia Barreto M.D.,Brittany L. Bychkovsky M.D., M.Sc.,Gilberto ded aquatic animals. Plant-sourced feedstuffs for aquatic animals include soybean meal, extruded soybean meal, fermented soybean meal, soybean protein concentrates, soybean protein isolates, leaf meal, hydrolyzed plant protein, wheat, wheat hydrolyzed protein, canola meal, cottonseed meal, peanut mea作者: deficiency 時(shí)間: 2025-3-29 09:01 作者: PUT 時(shí)間: 2025-3-29 12:09
Allan A. Lima Pereira M.D., Ph.D.,Andre Deeke Sasse M.D., Ph.D. vaccination failure. The present chapter is focused on the general introduction about CPV, evolution of its antigenic variants and the disease pathogenesis. The various diagnostic methods from conventional to latest one are discussed in detail with their merits and demerits. In addition, the curren作者: 盤旋 時(shí)間: 2025-3-29 19:04 作者: CRUMB 時(shí)間: 2025-3-29 21:25 作者: 修剪過(guò)的樹籬 時(shí)間: 2025-3-30 00:34 作者: 北極熊 時(shí)間: 2025-3-30 08:07 作者: vitreous-humor 時(shí)間: 2025-3-30 09:34
Gregory R. Pond Ph.D., P.Stat.,Samantha-Jo Caetano M.Sc. power is required. Also having good programmability of agents’ codes to realize complex behaviors is essential to realize it. On deploying such negotiating agents on an agent simulation, it is important to be able to handle detailed behaviors of them, as well as having a large scale simulation to c作者: 保守黨 時(shí)間: 2025-3-30 16:25 作者: 變形 時(shí)間: 2025-3-30 18:39 作者: Exclaim 時(shí)間: 2025-3-30 21:57
Raphael L. C. Araújo M.D., Ph.D.,Rachel P. Riechelmann M.D., Ph.D.n explanation matrix and an aberration detection mechanism for bidding strategies. The aberration detection is a mechanism that detects if one of the negotiating parties deviates from their expected behaviour, i.e. when a bid falls outside the range of expected behaviour for a specific strategy. The作者: PALSY 時(shí)間: 2025-3-31 03:37
Benjamin Haaland Ph.D.,Mina Georgieva M.S.n explanation matrix and an aberration detection mechanism for bidding strategies. The aberration detection is a mechanism that detects if one of the negotiating parties deviates from their expected behaviour, i.e. when a bid falls outside the range of expected behaviour for a specific strategy. The作者: 古董 時(shí)間: 2025-3-31 08:27 作者: affect 時(shí)間: 2025-3-31 12:16 作者: Peristalsis 時(shí)間: 2025-3-31 16:49 作者: somnambulism 時(shí)間: 2025-3-31 19:14
Rachel P. Riechelmann M.D., Ph.D.,Raphael L. C. Araújo M.D., Ph.D.,Axel Hinke Ph.D.of an electrolytic cell (indirect), or by stimulating the anodic or cathodic reactions (direct)..The presence, or absence of oxygen is a critical element in the mechanism of microbial corrosion. In the absence of oxygen the cathodic reaction involves the sulphate-reducing bacteria..At the present ti作者: 水土 時(shí)間: 2025-3-31 23:15
Everardo D. Saad M.D.g instead on the pan-antimicrobial spectrum of metronidazole or on published susceptibility profiles often determined with organisms isolated from patients at other, widely distant, hospitals. This approach can be seriously questioned in the light of increasing evidence of regional variation in anti作者: 自戀 時(shí)間: 2025-4-1 04:31 作者: 旋轉(zhuǎn)一周 時(shí)間: 2025-4-1 07:53 作者: 先鋒派 時(shí)間: 2025-4-1 11:32
Rodrigo Santa C. Guindalini M.D., Ph.D.,Rachel P. Riechelmann M.D., Ph.D.,Roberto Jun Arai M.Sc., Phram-positive bacterial activate the alternate complement cascade in the absence of any specific antibody, whereas Gram-negative species activate the classical complement cascade usually in the presence of specific antibody. However a combination of both pathways has been described for members of the作者: chemoprevention 時(shí)間: 2025-4-1 18:24
Pedro Aguiar Jr. M.D.,Carmelia Maria Noia Barreto M.D.,Brittany L. Bychkovsky M.D., M.Sc.,Gilberto dutrients are usually provided from ingested proteins and may also be derived from supplemental crystalline AA. AAs are the building blocks of protein (a major component of tissue growth) and, therefore, are the determinants of the growth performance and feed efficiency of farmed fish. Because protei
